What is known about the excretion of paricalcitol into breast milk?

Excretion of paricalcitol/metabolites into human milk is unknown, but animal data show milk excretion; infant risk cannot be excluded, so a decision must be made whether to discontinue breast-feeding or discontinue/withhold Zemplar therapy, weighing breast-feeding benefits for the child against treatment benefits for the woman.